WAVE LIFE SCIENCES LTD.

WVE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $42.7M $108.3M $113.3M $3.6M $41.0M $20.1M $16.0M $14.4M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $182.8M $159.7M $130.0M $115.9M $121.9M $130.9M $175.4M $134.4M
SG&A Expense $75.3M $59.0M $51.3M $50.5M $46.1M $42.5M $48.9M $39.5M
Operating Income $-215.4M $-110.4M $-68.0M $-162.7M $-127.0M $-153.4M $-208.3M $-159.5M
Operating Margin -504.1% -101.9% -60.0% -4,459.3% -310.1% -763.9% -1,303.4% -1,106.7%
Interest Expense
Pretax Income $-204.4M $-97.0M $-58.2M $-161.1M $-122.4M $-150.8M $-193.6M $-146.6M
Income Tax Expense $0 $0 $-677.0K $681.0K $-204.0K $-841.0K $0 $69.0K
Net Income $-204.4M $-97.0M $-57.5M $-161.8M $-122.2M $-149.9M $-193.6M $-146.7M
Net Margin -478.3% -89.6% -50.8% -4,434.7% -298.4% -746.7% -1,211.5% -1,017.4%
EPS (Basic) $-1.21 $-0.70 $-0.54 $-2.05 $-2.36 $-3.82 $-5.72 $-5.06
EPS (Diluted) $-1.21 $-0.70 $-0.54 $-2.05 $-2.36 $-3.82 $-5.72 $-5.06
Shares Outstanding (Basic) 168.6M 138.3M 106.1M 78.9M 51.8M 48.8M 34.3M 29.5M
Shares Outstanding (Diluted) 168.6M 138.3M 106.1M 78.9M 51.8M 48.8M 34.3M 29.5M
Dividends Per Share
← Newer Page 1 of 2 Older →